Allocetra: Off-The-Shelf, Universal, Macrophage Reprogramming Cell Therapy for Life-Threatening Diseases
Time: 2:30 pm
day: Day Two Track A PM
Details:
- Product description and mechanism of action
- Preclinical and clinical efficacy results – inflammatory indications
- Preclinical efficacy results in solid tumor models
